Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Net Cash Flow (2012 - 2026)

Iqvia Holdings' (IQV) quarterly Net Cash Flow came in at -$37.0 million in Q2 2026, down 115.29% year-over-year from $242.0 million in Q2 2025, and down 236.36% quarter-over-quarter from -$11.0 million in Q1 2026.

Analysis

Iqvia Holdings (IQV) Net Cash Flow (2012 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Net Cash Flow across 15 years of filings, most recently posting -$37.0 million for Q2 2026.

  • In Q2 2026, Net Cash Flow fell 115.29% year-over-year to -$37.0 million; the TTM figure through Jun 2026 stood at -$96.0 million (down 122.22% YoY), while the FY2025 annual figure was $199.0 million, down 49.49% from the prior year.
  • Net Cash Flow came in at -$37.0 million for Q2 2026 at Iqvia Holdings, down from -$11.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $282.0 million in Q1 2023 to a low of -$214.0 million in Q3 2025.
  • Average Net Cash Flow over 5 years is $35.2 million, with a median of $22.0 million recorded in 2022.
  • Year-over-year, Net Cash Flow jumped 623.08% in 2023 and tumbled 1326.67% in 2025.
  • Over 5 years, Net Cash Flow stood at -$110.0 million in 2022, then jumped by 204.55% to $115.0 million in 2023, then surged by 73.91% to $200.0 million in 2024, then retreated by 17.0% to $166.0 million in 2025, then plunged by 122.29% to -$37.0 million in 2026.
  • Per Business Quant data, the three most recent Net Cash Flow figures were -$37.0 million in Q2 2026, -$11.0 million in Q1 2026, and $166.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -37.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -150.21 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 164.82 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 43.16 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 21.90 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -16.70 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -514,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -2.71 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -3.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.00 Mn
Mar 31, 2026 -11.00 Mn
Dec 31, 2025 166.00 Mn
Sep 30, 2025 -214.00 Mn
Jun 30, 2025 242.00 Mn
Mar 31, 2025 5.00 Mn
Dec 31, 2024 200.00 Mn
Sep 30, 2024 -15.00 Mn
Jun 30, 2024 107.00 Mn
Mar 31, 2024 102.00 Mn
Dec 31, 2023 115.00 Mn
Sep 30, 2023 -134.00 Mn
Jun 30, 2023 -99.00 Mn
Mar 31, 2023 282.00 Mn
Dec 31, 2022 -110.00 Mn
Sep 30, 2022 -105.00 Mn
Jun 30, 2022 101.00 Mn
Mar 31, 2022 39.00 Mn
Dec 31, 2021 -93.00 Mn
Sep 30, 2021 -317.00 Mn